We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Methylation Analysis in Newborn Screening for Fragile X Syndrome

David E. Godler, PhD1; David J. Amor, PhD, MD1; Howard R. Slater, PhD1
[+] Author Affiliations
1The Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne/Parkville, Victoria, Australia
JAMA Neurol. 2014;71(6):800. doi:10.1001/jamaneurol.2014.142.
Text Size: A A A
Published online


To the Editor In a recent issue of JAMA Neurology, Tassone1 presented arguments for and against newborn screening (NBS) for fragile X syndrome (FXS), which is caused by large CGG expansion mutations (FM) in the gene FMR1. Tassone described the drawbacks of detecting the smaller gray-zone (GZ) and premutation (PM) alleles, which do not cause FXS but are nonetheless detected by assays based on CGG-expansion sizing. A contentious ethical issue is the detection of the late-onset conditions, fragile X–associated tremor/ataxia syndrome and fragile X–associated primary ovarian insufficiency, in infant carriers of PM alleles and the incomplete understanding of the clinical significance of GZ and PM alleles in child development. The justification for including GZ alleles in the screen is debatable because follow-up cascade testing of relatives of GZ allele carriers would yield very few carriers of PM or FM alleles. Furthermore, because the reported prevalence1 of GZ in the general population is approximately 1 in 26, from a funding and infrastructure perspective, the task of providing pretest counselling and posttest follow-up would be monumental if not impossible.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





June 1, 2014
Flora Tassone, PhD
1Department of Biochemistry and Molecular Medicine, MIND Institute, University of California, Davis, School of Medicine
JAMA Neurol. 2014;71(6):800-801. doi:10.1001/jamaneurol.2014.454.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...